![ELF key visual](https://marketing.webassets.siemens-healthineers.com/f23f8debc71942bc/77190c778a73/v/70cf5528a43c/LD_ELF_Michael_IMAGE_21_Rev01.jpg)
The ELF Test
Assess the risk of disease progression in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) with a simple blood test
Did this information help you?
References
1
Patel P, et al. Hepatol Commun. 2018;2:893-905.
2
Karlas T, et al. PLoS ONE. 2015;10(11):e0141649.
3
Sanyal AJ, et al. Hepatology. 2019 Apr 16. doi: 10.1002/hep.30664. [Epub ahead of print].
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.